Literature DB >> 20419392

White blood cell subtypes after STEMI: temporal evolution, association with cardiovascular magnetic resonance--derived infarct size and impact on outcome.

Oliver Husser1, Vicente Bodi, Juan Sanchis, Julio Nunez, Luis Mainar, Francisco Javier Chorro, Maria Pilar Lopez-Lereu, Jose Vicente Monmeneu, Fabian Chaustre, Maria J Forteza, Isabel Trapero, Francisco Dasi, Isabel Benet, Günter A J Riegger, Angel Llacer.   

Abstract

The evolution of white blood cells after ST elevation myocardial infarction (STEMI) and their association with infarct size and major adverse cardiac events (MACE) remains unclear. Two hundred eleven patients underwent CMR after STEMI. Infarct mass (grams) was determined. Neutrophil, lymphocyte, and monocyte counts (×1,000 cells/ml) were measured upon arrival and at 12, 24, 48, 72, and 96 h. Patients with large infarctions (3rd tertile ≥ 28.5 g vs. 1st and 2nd tertiles < 28.5 g) showed a larger neutrophil count at 12 h (14.8 ± 4.8 vs. 11.4 ± 3.3, p < 0.0001) and an increased monocyte count (maximum at 24 h (0.65[0.50-0.91] vs. 0.55[0.42-0.71], p = 0.004)) but no difference in lymphocyte count. Neutrophil count at 12 h independently predicted large infarctions (OR 1.14, 95%CI [1.04-1.26], p = 0.008). During follow-up (median 504 days), 25 MACE occurred. Neutrophil count at 96 h independently predicted MACE (HR 1.2, 95%CI [1.1-1.4], p = 0.003). Large infarctions show a marked neutrophil peak and an increasing monocyte count. Neutrophil count independently predicts large infarctions and MACE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20419392     DOI: 10.1007/s10753-010-9209-0

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  20 in total

Review 1.  Normal responses to injury prevent systemic inflammation and can be immunosuppressive.

Authors:  R S Munford; J Pugin
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

Review 2.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

3.  Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning.

Authors:  Vicente Bodí; Juan Sanchis; María P López-Lereu; Antonio Losada; Julio Núñez; Mauricio Pellicer; Vicente Bertomeu; Francisco J Chorro; Angel Llácer
Journal:  J Am Coll Cardiol       Date:  2005-10-10       Impact factor: 24.094

4.  Evolution of 5 cardiovascular magnetic resonance-derived viability indexes after reperfused myocardial infarction.

Authors:  Vicente Bodí; Juan Sanchis; Maria P Lopez-Lereu; Julio Nunez; Luis Mainar; Mauricio Pellicer; Roberto Sanz; Cristina Gomez; Maria J Bosch; Oliver Husser; Francisco J Chorro; Angel Llacer
Journal:  Am Heart J       Date:  2007-04       Impact factor: 4.749

5.  Universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Harvey D White
Journal:  J Am Coll Cardiol       Date:  2007-11-27       Impact factor: 24.094

Review 6.  Prognostic value of leukocytosis in acute coronary syndromes: the cinderella of the inflammatory markers.

Authors:  J Núñez; E Núñez; J Sanchis; V Bodí; A Llàcer
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

7.  Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy.

Authors:  H V Barron; C P Cannon; S A Murphy; E Braunwald; C M Gibson
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

Review 8.  Prevention of lymphocyte apoptosis--a potential treatment of sepsis?

Authors:  Richard S Hotchkiss; Craig M Coopersmith; Irene E Karl
Journal:  Clin Infect Dis       Date:  2005-11-15       Impact factor: 9.079

Review 9.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur Heart J       Date:  2008-09-17       Impact factor: 29.983

10.  Post-reperfusion lymphopenia and microvascular obstruction in ST-segment elevation acute myocardial infarction.

Authors:  Vicente Bodí; Juan Sanchis; Julio Núñez; Eva Rumiza; Luis Mainar; María P López-Lereu; José V Monmeneu; Ricardo Oltra; María J Forteza; Francisco J Chorro; Angel Llácer
Journal:  Rev Esp Cardiol       Date:  2009-10       Impact factor: 4.753

View more
  15 in total

1.  Impact of white blood cell count on myocardial salvage, infarct size, and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a magnetic resonance imaging study.

Authors:  Seungmin Chung; Young Bin Song; Joo-Yong Hahn; Sung-A Chang; Sang-Chol Lee; Yeon Hyeon Choe; Seung-Hyuk Choi; Jin-Ho Choi; Sang Hoon Lee; Jae K Oh; Hyeon-Cheol Gwon
Journal:  Int J Cardiovasc Imaging       Date:  2013-10-09       Impact factor: 2.357

2.  The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality.

Authors:  Minke H T Hartman; Ruben N Eppinga; Pieter J J Vlaar; Chris P H Lexis; Erik Lipsic; Joost D E Haeck; Dirk J van Veldhuisen; Iwan C C van der Horst; Pim van der Harst
Journal:  Clin Cardiol       Date:  2016-12-27       Impact factor: 2.882

3.  Stage-dependent detection of CD14+ and CD16+ cells in the human heart after myocardial infarction.

Authors:  Frauke S Czepluch; Magdalena Schlegel; Felix Bremmer; Carl L Behnes; Gerd Hasenfuss; Katrin Schäfer
Journal:  Virchows Arch       Date:  2013-07-20       Impact factor: 4.064

4.  Pathophysiology of LV Remodeling in Survivors of STEMI: Inflammation, Remote Myocardium, and Prognosis.

Authors:  David Carrick; Caroline Haig; Sam Rauhalammi; Nadeem Ahmed; Ify Mordi; Margaret McEntegart; Mark C Petrie; Hany Eteiba; Mitchell Lindsay; Stuart Watkins; Stuart Hood; Andrew Davie; Ahmed Mahrous; Naveed Sattar; Paul Welsh; Niko Tzemos; Aleksandra Radjenovic; Ian Ford; Keith G Oldroyd; Colin Berry
Journal:  JACC Cardiovasc Imaging       Date:  2015-06-17

5.  Elevated mean neutrophil volume represents altered neutrophil composition and reflects damage after myocardial infarction.

Authors:  G P J van Hout; W W van Solinge; C M Gijsberts; M P J Teuben; P H C Leliefeld; M Heeres; F Nijhoff; S de Jong; L Bosch; S C A de Jager; A Huisman; P R Stella; G Pasterkamp; L J Koenderman; I E Hoefer
Journal:  Basic Res Cardiol       Date:  2015-10-14       Impact factor: 17.165

6.  Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation.

Authors:  M Verdoia; A Schaffer; L Barbieri; G Di Giovine; G Bellomo; P Marino; H Suryapranata; G De Luca
Journal:  Neth Heart J       Date:  2016-07       Impact factor: 2.380

7.  Echocardiographic epicardial fat thickness is a predictor for target vessel revascularization in patients with ST-elevation myocardial infarction.

Authors:  Jin-Sun Park; You-Hong Lee; Kyoung-Woo Seo; Byoung-Joo Choi; So-Yeon Choi; Myeong-Ho Yoon; Gyo-Seung Hwang; Seung-Jea Tahk; Joon-Han Shin
Journal:  Lipids Health Dis       Date:  2016-11-16       Impact factor: 3.876

8.  Importance of prognostic value of neutrophil to lymphocyte ratio in patients with ST-elevation myocardial infarction.

Authors:  Jin-Sun Park; Kyoung-Woo Seo; Byoung-Joo Choi; So-Yeon Choi; Myeong-Ho Yoon; Gyo-Seung Hwang; Seung-Jea Tahk; Joon-Han Shin
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

9.  High-throughput 13-parameter immunophenotyping identifies shifts in the circulating T-cell compartment following reperfusion in patients with acute myocardial infarction.

Authors:  Jedrzej Hoffmann; Karel Fiser; Jolanta Weaver; Ian Dimmick; Monika Loeher; Hanspeter Pircher; Carmen Martin-Ruiz; Murugapathy Veerasamy; Bernard Keavney; Thomas von Zglinicki; Ioakim Spyridopoulos
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

10.  Platelet-to-lymphocyte ratio but not neutrophil-to-lymphocyte ratio predicts high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndrome.

Authors:  Edem Efe; Ibrahim Kocayiğit; Pabuccu Mustafa Türker; Küçükukur Murat; Alpaslan Erkan; Taş Sedat; Çil Alper; Aksoy Murat Necati; Vural Mustafa Gökhan; Akdeniz Bahri
Journal:  Indian J Pharmacol       Date:  2016 Jul-Aug       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.